ULBI

Rating neutralAI MemoPost-earnings T+3

Ultralife

As of 2026-08-08/Post-earnings T+3/Confidence high

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-08 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

high

Horizon

—

Key catalyst

Q2 profitability rebound and record backlog • 2026-08-07

Base target: $6 / p=50% prob

Biggest risk

Revenue still declined, Battery & Energy Products sales fell 3.7%, and reported gross margin benefited from a $1.1 million refund and favorable mix. Backlog conversion, product launches, and sustained manufacturing improvement remain unproven. No verified post-print analyst revisions or target changes were available.

Invalidation

Break below $5 or thesis failure.

What would change my mind?

Ultralife delivered materially better Q2 profitability, a record backlog, and management commentary on new defense-related products and multi-year opportunities. The positive initial reaction suggests investors recognized the margin and backlog improvement. [#SEC-8K-2026-08-07]

Research note

Recommendation

neutral

Confidence

high

As of

2026-08-08

Base target

p=50%

Bull target

p=25%

Bear target

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Margin sustainability test
Backlog and new-product conversion
Ultralife delivered materially better Q2 profitability, a record backlog, and management commentary on new defense-related products and multi-year opportunities.

BearKey bullets

Backlog conversion and new-product production timing are execution-dependent and lack detailed quantitative guidance.
Gross-margin improvement was partly driven by a $1.1 million IEEPA refund and favorable product mix, so normalization could pressure future margins.
No verified analyst target revisions or estimate changes were available, and the low-coverage peer set is not sufficiently comparable.

WatchKey bullets

Q2 profitability rebound and record backlog

Summary

High-level snapshot

Recommendation

neutral

Model confidence

high

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $6 (p=50%)

Target spread vs base: +21% / -25%

Scenario probabilities

Bull Target: $7 (p=25%)Base Target: $6 (p=50%)Bear Target: $5 (p=25%)

Commentary

The post-print market reaction was positive: the latest finance quote showed $6.35, up $1.04, or approximately 19.5%, from the prior close. News tone is modestly positive because profitability and backlog improved, but revenue remained soft and the margin gain included a refund. Social coverage, options data, employee sentiment, and verified analyst revisions were unavailable; confidence therefore remains moderate rather than high.

As of 2026-08-08 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Margin sustainability test
Backlog and new-product conversion

Scenarios

Bull Target (Scenario probability)

$7 / p=25% prob

Base Target (Scenario probability)

$6 / p=50% prob

Bear Target (Scenario probability)

$5 / p=25% prob

Analysis 2026-08-08 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.35

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-07
Q2 profitability rebound and record backlog
Q2 sales declined 1.3% year over year to $47.9 million, but GAAP EPS rose to $0.15 from $0.05, adjusted EBITDA rose to $6.1 million from $4.1 million, and backlog reached a record $117.5 million. Gross-margin improvement partly reflected a $1.1 million IEEPA refund and favorable mix. Management cited new products and defense programs as support for profitable 2026 growth. [#SEC-8K-2026-08-07] [#8-K-2026-08-07]
Prob 75.00% • Move 8.00% • Priced-in 80.00%

Short-term Catalysts

Next few weeks

Margin sustainability test
2026-11-06
The next quarterly update should show whether manufacturing-efficiency gains persist after the IEEPA refund and favorable mix benefit, while higher product-development spending and one-time costs remain execution considerations. [#SEC-8K-2026-08-07]
Prob 55% • Move 7% • Priced-in 45%

Long-term Catalysts

Months to a year

Backlog and new-product conversion
2027-08-08
Management said Communications Systems products are moving through capture, multiple government/defense products are planned for launch later in 2026, and several Battery & Energy Programs may transition into production later this year. Conversion timing remains unquantified. [#SEC-8K-2026-08-07]
Prob 55% • Move 18% • Priced-in 45%

Risks

Backlog conversion and new-product production timing are execution-dependent and lack detailed quantitative guidance.
Gross-margin improvement was partly driven by a $1.1 million IEEPA refund and favorable product mix, so normalization could pressure future margins.
No verified analyst target revisions or estimate changes were available, and the low-coverage peer set is not sufficiently comparable.
Operating expenses increased because of new-product development and one-time costs; acquisition financing also contributes interest expense.
Revenue declined 1.3% year over year, with weakness in commercial, oil and gas, industrial, and government/defense sales.

Peers

Symbol	Summary
BNC	Same-sector, similar-market-cap candidate from the packet; operating comparability and valuation data were not validated.
BWEN	Same-sector, similar-market-cap candidate from the packet; operating comparability and valuation data were not validated.
BYRN	Same-sector, similar-market-cap candidate from the packet; operating comparability and valuation data were not validated.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-08

Loading AI feed…

Symbol

Summary

BNC

Same-sector, similar-market-cap candidate from the packet; operating comparability and valuation data were not validated.

BWEN

Same-sector, similar-market-cap candidate from the packet; operating comparability and valuation data were not validated.

BYRN

Same-sector, similar-market-cap candidate from the packet; operating comparability and valuation data were not validated.